Found 0 matching trials
Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT
N/AThis study aims to develop highly sensitive methods for early detection of ...
Location
Department of Hematology, Aarhus University Hospital
Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT
PHASE2The study is designed as a two arm randomized Phase II, multicenter trial c...
Location
Saint Antoine Hospital - Hematology Department
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
PHASE1To learn if adding a healthy person's natural killer (NK) cells to the comb...
Location
Case Western Reserve University
ALLO-SCT in Elderly Patients With Hematological Disease
N/ARetrospective, observational, multicentre, spontaneous, non-interventional ...
Location
Azienda Ospedaliero-Universitaria Ospedali Riuniti
Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host Disease
NAThis study aims to assess the safety and efficacy of autologous fecal micro...
Location
Rambam Health Care Campus
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
PHASE1Allogeneic stem cell transplant is used to treat a variety of blood cancers...
Location
Dartmouth-Hitchcock Medical Center
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
PHASE3This study will evaluate a new maintenance therapy with the aim of improvin...
Location
The Queen Elizabeth Hospital
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
PHASE1Sorfenib works by slowing the spread of cancer cells. It has been used in o...
Location
Massachusetts General Hospital
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
PHASE1RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath
PHASE2Allogeneic transplantation is used to treat many malignant and non-malignan...
Location
Duke University Health Systems